Navigation Links
Vectibix(R) in Combination With Chemotherapy Significantly Improves Progression-Free Survival in Second-Line Metastatic Colorectal Cancer
Date:9/22/2009

THOUSAND OAKS, Calif., Sept. 22 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) today announced detailed results from the Phase 3 '181' trial evaluating Vectibix((R)) (panitumumab) in combination with FOLFIRI (an irinotecan based chemotherapy), as a second-line treatment for metastatic colorectal cancer (mCRC). In this trial, Vectibix significantly improved progression-free survival (PFS) in patients with KRAS wild-type mCRC. These results were presented at the 2009 ECCO 15 - ESMO 34 European Multidisciplinary Congress in Berlin, Germany (Abstract Number 14LBA).

The addition of Vectibix to FOLFIRI significantly improved median PFS (co-primary endpoint) by two months (5.9 versus 3.9 months for patients treated with FOLFIRI alone, hazard ratio 0.73, p=0.004) in patients with KRAS wild-type mCRC. Although numerically greater (14.5 months versus 12.5 months; hazard ratio 0.85), the improvement in median overall survival (co-primary endpoint) in the Vectibix arm did not achieve statistical significance (p=0.115) in the same patient population.

Further, the addition of Vectibix to FOLFIRI resulted in greater than a three-fold improvement (35 percent versus 10 percent) in response rate in the KRAS wild-type patient population as measured by a blinded central review.

"This study showed that Vectibix can be safely administered in combination with FOLFIRI chemotherapy. Vectibix delayed disease progression by more than half compared to FOLFIRI alone in patients with previously treated KRAS wild-type colorectal cancer," said Marc Peeters, M.D., Ph.D., coordinator of Digestive Oncology Unit, University Hospital Ghent and the study's principal investigator. "Further, the response rate seen in this trial is among the highest ever re
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer
2. Vectibix(R) Significantly Improved Progression-Free Survival in Second-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer
3. CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
4. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
5. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
6. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
7. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
8. Vion Pharmaceuticals Announces Initiation of a Phase I/II Trial of Cloretazine(R) (VNP40101M) in Combination with Temodar(R) in Adult Brain Tumors
9. New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy
10. New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients With Complicated Skin Infections, Including MRSA
11. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 2015 North American ophthalmology glaucoma ... 2014, and is estimated to grow to $138.3 million ... to 2019. Browse through the TOC of ... analysis of industry trends and segments, with the help ... Early buyers will receive 10% ...
(Date:5/5/2015)... and NIJMEGEN, the Netherlands ... medical device company developing lower esophageal sphincter (LES) ... long-term, 3-year, positive safety and efficacy results. The ... of both heartburn and regurgitation and the "gold-standard" ... test) with near-complete elimination of dependence on daily ...
(Date:5/5/2015)... LONG BEACH, Calif. and ST. ... with diabetes, high blood pressure or high cholesterol may ... part of performance-based networks, according to early results of ... Express Scripts (NASDAQ: ESRX ). "Pharmacists ... professionals and their frequent interactions with our members presents ...
Breaking Medicine Technology:North America Ophthalmology Glaucoma Surgery Device Market is Expected to Reach $138.3 Million by 2019, at a CAGR of 7.8% From 2014 to 2019 2North America Ophthalmology Glaucoma Surgery Device Market is Expected to Reach $138.3 Million by 2019, at a CAGR of 7.8% From 2014 to 2019 3Excellent three year results of EndoStim therapy for severe reflux disease presented at the SAGES Annual Meeting in Nashville. 2Excellent three year results of EndoStim therapy for severe reflux disease presented at the SAGES Annual Meeting in Nashville. 3SCAN Health Plan, Express Scripts' Quality Network Improves Medicare Beneficiary Health 2SCAN Health Plan, Express Scripts' Quality Network Improves Medicare Beneficiary Health 3SCAN Health Plan, Express Scripts' Quality Network Improves Medicare Beneficiary Health 4
... Reportlinker.com announces that a new market ... Asia Pacific Hospital Supplies ... http://www.reportlinker.com/p0493115/Asia-Pacific-Hospital-Supplies-Market-Outlook-to-2017.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic Asia Pacific ... Summary GlobalData,s ...
... Borun Corporation (NYSE: BORN ; "Borun" or ... edible alcohol in China, today announced unaudited financial results ... Jinmiao Wang, Chairman and Chief Executive Officer of Borun, ... another quarter of strong financial performance.  We solidly executed ...
Cached Medicine Technology:Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 2Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 3Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 4Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 5Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 6Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 7Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 8Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 9Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 10Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 11Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 12Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 13Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 14Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017 15China New Borun Announces First Quarter 2011 Financial Results 2China New Borun Announces First Quarter 2011 Financial Results 3China New Borun Announces First Quarter 2011 Financial Results 4China New Borun Announces First Quarter 2011 Financial Results 5China New Borun Announces First Quarter 2011 Financial Results 6China New Borun Announces First Quarter 2011 Financial Results 7China New Borun Announces First Quarter 2011 Financial Results 8
(Date:5/5/2015)... New York, NY (PRWEB) May 05, 2015 ... Maternity Health IVF Clinic in Greece, an experienced ... evaluation and treatment of infertility for patients around the ... has partnered with VisitandCare.com. Greece unquestionably remains a global ... the most talented and hard-working fertility specialists in the ...
(Date:5/5/2015)... May 05, 2015 From the ... the established leader in enabling enterprise collaboration across ... help customers speed up and simplify the move ... AvePoint Solutions for Office 365 enable ... while ensuring sustainable user adoption and effectively managing ...
(Date:5/5/2015)... Patricia George knows all too well the debilitating effects ... specialist at the University of Pittsburgh Medical Center (UPMC), ... idea entered her mind for Team PHenomenal Hope. ... 2010 PHA International Conference,” George recalled. “The speakers – ... climb up Mt. Kilimanjaro and I remember thinking how ...
(Date:5/5/2015)... 05, 2015 This year, PolyU researchers ... Special Merit Awards, three Gold Medals and four Silver ... described as follows: , (1) Grand Prize and Gold ... for Fashion Design and Fitting, Principal Investigator: Dr Allan ... apparel industry relies very much on the “mannequin” for ...
(Date:5/5/2015)... Grand Bahama (PRWEB) May 05, 2015 ... its Orthopedic Lifestyle Report today. The study was conducted ... conditions such as osteoarthritis and sports-related injuries ... pain and stiffness was the most prevalent symptom reported ... functionality such as walking, standing and bending over. Over ...
Breaking Medicine News(10 mins):Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 2Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 3Health News:AvePoint Unveils New Solutions for Microsoft Office 365 & Azure at Microsoft Ignite 2015 2Health News:AvePoint Unveils New Solutions for Microsoft Office 365 & Azure at Microsoft Ignite 2015 3Health News:World PH Day: Team PHenomenal Hope Races to Spread the Word about Pulmonary Hypertension 2Health News:PolyU wins top prizes in Geneva’s Invention Expo 2Health News:PolyU wins top prizes in Geneva’s Invention Expo 3Health News:PolyU wins top prizes in Geneva’s Invention Expo 4Health News:PolyU wins top prizes in Geneva’s Invention Expo 5Health News:Okyanos Study Finds Orthopedic Patients Plagued with Pain 2Health News:Okyanos Study Finds Orthopedic Patients Plagued with Pain 3
... Receive Spirit of Stonewall Award, BOSTON, June 4 ... and tree lighting, presented by Citibank, will,run from 7-9 ... for the,Arts (BCA) on Tremont Street in Boston,s South ... year,s Pridelights,will feature appearances by Bravo TV,s "Top Chef" ...
... time a mother nurses doesn,t protect the baby, study ... year, an estimated 200,000 babies worldwide are infected with ... a new study suggests that a short-term drug regimen ... is very practical, and these drugs are relatively cheap. ...
... finds a discouraging lack of progress among Hispanic children ... school students are more likely to engage in risky ... than white or black teens, U.S. health officials said ... many behaviors among high school students, Hispanic students remain ...
... and ... healthcare industry, NEW YORK, June 4 Carl Marks ... LLC (CMHP) to the firm,s,business units. CMHP will focus on ... industry., "Carl Marks Healthcare Partners adds another dimension to ...
... Walgreen Co. of,Deerfield, Ill., has agreed to pay ... 2005, it improperly switched patients to different versions ... order to,increase its reimbursement from Medicaid, the Justice ... retail pharmacies throughout the,U.S., switched the prescriptions for ...
... Inc. is,proud to introduce the first DTC Hall of ... who have made significant contributions to,advancing the Direct-to-Consumer marketing ... in DTC marketing., To inaugurate the DTC Hall ... inducted and announced. The official Hall of Fame program ...
Cached Medicine News:Health News:Fifteenth Annual Pridelights Goes Green 2Health News:Drug Regimen Prevents AIDS Transmission Via Breast Milk 2Health News:Drug Regimen Prevents AIDS Transmission Via Breast Milk 3Health News:Fewer U.S. High School Students Engage in Risky Behaviors 2Health News:Fewer U.S. High School Students Engage in Risky Behaviors 3Health News:Carl Marks Establishes New Healthcare Business Unit 2Health News:Walgreens to Pay $35 Million to U.S., 46 States & Puerto Rico to Settle Medicaid Prescription Drug Fraud Allegations 2Health News:DTC Perspectives, Inc. Announces the New DTC Hall of Fame Award 2
... The HypercleanTM 2 fume ... for enclosing benchtop equipment. ... fit comfortably inside the Hyperclean ... fume containment system unit comes ...
Reusable shielded cable...
... OIA test features a dual-detection technology to ... for children under age 5 with a ... in just over 15 minutes. This combination ... to decrease costs for unnecessary ancillary testing, ...
... A/B test combines performance equivalence to 14-day viral ... or B with a simple, easy-to-use test with ... has all the same procedural steps as our ... you decrease costs for unnecessary ancillary testing, improve ...
Medicine Products: